Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling

Immunity

Volumn 39, Issue 3, 2013, Pages 454-469

  Qiao, Yu ^a   Giannopoulou, Eugenia G ^b   Chan, Chun Hin ^a   Park, Sung ho ^a   Gong, Shiaoching ^a   Chen, Janice ^a,d   Hu, Xiaoyu ^a,b   Elemento, Olivier ^b   Ivashkiv, Lionel B ^a,b,c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Weill Cornell Graduate School of Biomedical Sciences   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; GAMMA INTERFERON; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; INTERLEUKIN 12P40; INTERLEUKIN 6; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; CYTOKINE; HISTONE; IRF1 PROTEIN, HUMAN; JANUS KINASE; PROTEIN BINDING; RNA POLYMERASE II; STAT1 PROTEIN, HUMAN; TOLL LIKE RECEPTOR;

ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINE PRODUCTION; ENHANCER REGION; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ACETYLATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; ENZYME ACTIVATION; GENETICS; METABOLISM;

ACETYLATION; CELLS, CULTURED; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINES; ENZYME ACTIVATION; HISTONES; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-6; JANUS KINASES; MACROPHAGES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA POLYMERASE II; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTORS;

EID: 84884355522     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.08.009     Document Type: Article

References (45)

1. Adams D.O., Hamilton T.A. Molecular transductional mechanisms by which IFN gamma and other signals regulate macrophage development. Immunol. Rev. 1987, 97:5-27.
2. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M., Epstein C.B., Frietze S., Harrow J., Kaul R., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
3. Buecker C., Wysocka J. Enhancers as information integration hubs in development: lessons from genomics. Trends Genet. 2012, 28:276-284.
4. Chatterjee-Kishore M., Wright K.L., Ting J.P., Stark G.R. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 2000, 19:4111-4122.
5. Chen J., Ivashkiv L.B. IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc. Natl. Acad. Sci. USA 2010, 107:19438-19443.
6. De Santa F., Barozzi I., Mietton F., Ghisletti S., Polletti S., Tusi B.K., Muller H., Ragoussis J., Wei C.L., Natoli G. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010, 8:e1000384.
7. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
8. Escoubet-Lozach L., Benner C., Kaikkonen M.U., Lozach J., Heinz S., Spann N.J., Crotti A., Stender J., Ghisletti S., Reichart D., et al. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 2011, 7:e1002401.
9. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.
10. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., Gregory L., Lonie L., Chew A., Wei C.L., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32:317-328.
11. Giannopoulou E.G., Elemento O. An integrated ChIP-seq analysis platform with customizable workflows. BMC Bioinformatics 2011, 12:277.
12. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and Tcells. Nat. Rev. Immunol. 2010, 10:365-376.
13. Hamilton J.A., Tak P.P. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 2009, 60:1210-1221.
14. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., Cheng J.X., Murre C., Singh H., Glass C.K. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
15. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
16. Hu X., Herrero C., Li W.P., Antoniv T.T., Falck-Pedersen E., Koch A.E., Woods J.M., Haines G.K., Ivashkiv L.B. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat. Immunol. 2002, 3:859-866.
17. Hu X., Chen J., Wang L., Ivashkiv L.B. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J.Leukoc. Biol. 2007, 82:237-243.
18. Hu X., Chakravarty S.D., Ivashkiv L.B. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 2008, 226:41-56.
19. Ivashkiv L.B. Epigenetic regulation of macrophage polarization and function. Trends Immunol. 2013, 34:216-223.
20. Ivashkiv L.B., Hu X. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?. Arthritis Rheum. 2003, 48:2092-2096.
21. Jin F., Li Y., Ren B., Natarajan R. PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc. Natl. Acad. Sci. USA 2011, 108:5290-5295.
22. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
23. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
24. Natoli G., Ghisletti S., Barozzi I. The genomic landscapes of inflammation. Genes Dev. 2011, 25:101-106.
25. Neph S., Vierstra J., Stergachis A.B., Reynolds A.P., Haugen E., Vernot B., Thurman R.E., John S., Sandstrom R., Johnson A.K., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012, 489:83-90.
26. Nicodeme E., Jeffrey K.L., Schaefer U., Beinke S., Dewell S., Chung C.W., Chandwani R., Marazzi I., Wilson P., Coste H., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123.
27. Ostuni R., Piccolo V., Barozzi I., Polletti S., Termanini A., Bonifacio S., Curina A., Prosperini E., Ghisletti S., Natoli G. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.
28. Park S.H., Park-Min K.H., Chen J., Hu X., Ivashkiv L.B. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 2011, 12:607-615.
29. Pattison M.J., Mackenzie K.F., Arthur J.S. Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback. J.Immunol. 2012, 189:2784-2792.
30. Pham T.H., Benner C., Lichtinger M., Schwarzfischer L., Hu Y., Andreesen R., Chen W., Rehli M. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 2012, 119:e161-e171.
31. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., Black J.C., Hoffmann A., Carey M., Smale S.T. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138:114-128.
32. Saccani S., Pantano S., Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 2002, 3:69-75.
33. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J.Leukoc. Biol. 2004, 75:163-189.
34. Schroder K., Sweet M.J., Hume D.A. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 2006, 211:511-524.
35. Smale S.T. Selective transcription in response to an inflammatory stimulus. Cell 2010, 140:833-844.
36. Smale S.T. Transcriptional regulation in the innate immune system. Curr. Opin. Immunol. 2012, 24:51-57.
37. Spitz F., Furlong E.E. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet. 2012, 13:613-626.
38. St Clair E.W. Novel targeted therapies for autoimmunity. Curr. Opin. Immunol. 2009, 21:648-657.
39. Stark G.R., Darnell J.E. The JAK-STAT pathway at twenty. Immunity 2012, 36:503-514.
40. Suganuma T., Workman J.L. Signals and combinatorial functions of histone modifications. Annu. Rev. Biochem. 2011, 80:473-499.
41. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
42. Thurman R.E., Rynes E., Humbert R., Vierstra J., Maurano M.T., Haugen E., Sheffield N.C., Stergachis A.B., Wang H., Vernot B., et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82.
43. Vahedi G., Takahashi H., Nakayamada S., Sun H.W., Sartorelli V., Kanno Y., O'Shea J.J. STATs shape the active enhancer landscape of Tcell populations. Cell 2012, 151:981-993.
44. Weinmann A.S., Mitchell D.M., Sanjabi S., Bradley M.N., Hoffmann A., Liou H.C., Smale S.T. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2001, 2:51-57.
45. Zhou L., Nazarian A.A., Xu J., Tantin D., Corcoran L.M., Smale S.T. An inducible enhancer required for Il12b promoter activity in an insulated chromatin environment. Mol. Cell. Biol. 2007, 27:2698-2712.